Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: J Biopharm Stat. 2012;22(2):401–415. doi: 10.1080/10543406.2010.544437

Table 1.

Bias and coverage probability (median length) of 95% two-sided confidence intervals for the ACER - simulation study for scenario 1

Censoring Light censoring Heavy censoring

Sample size Survival time Uniform Exponential Uniform Exponential
100 ACER-naive −356 −383 −572 −632

ACER (simple-weighted) 6 7 15 4
 Fieller-normal 92.3% (316) 94.6% (359) 90.8% (366) 92.0% (441)
 Taylor-normal 91.7% (313) 93.6% (353) 89.6% (361) 90.7% (433)
 Bootstrap-percentile 91.8% (314) 93.9% (354) 92.3% (389) 92.7% (497)
 Bootstrap-normal 92.2% (318) 93.8% (357) 93.3% (393) 94.0% (503)

ACER (improved) 6 7 13 4
 Fieller-normal 92.8% (305) 94.2% (343) 92.4% (339) 94.4% (409)
 Taylor-normal 91.7% (302) 93.6% (337) 89.6% (334) 90.4% (402)
 Bootstrap-percentile 92.5% (300) 93.5% (337) 92.2% (353) 94.4% (448)
 Bootstrap-normal 92.0% (305) 93.4% (340) 93.0% (357) 94.3% (457)

200 ACER-naive −361 −383 −589 −638

ACER (simple-weighted) 2 6 7 11
 Fieller-normal 92.7% (236) 94.2% (265) 93.1% (276) 94.1% (329)
 Taylor-normal 92.2% (235) 94.0% (263) 92.6% (274) 93.3% (326)
 Bootstrap-percentile 92.5% (231) 93.0% (263) 93.5% (283) 93.4% (335)
 Bootstrap-normal 92.2% (233) 93.8% (264) 93.4% (285) 94.1% (339)

ACER (improved) 2 6 5 9
 Fieller-normal 92.8% (226) 94.6% (254) 93.2% (253) 94.4% (293)
 Taylor-normal 92.2% (225) 94.0% (252) 92.6% (252) 93.3% (290)
 Bootstrap-percentile 91.9% (223) 93.3% (251) 92.8% (254) 93.5% (290)
 Bootstrap-normal 91.8% (225) 93.7% (253) 92.5% (256) 93.7% (297)

Naive denotes the estimator that does not account for censoring in cost. Bias is the absolute bias in the point estimate. For bootstrap methods, B=1000 replicates were generated. 1000 simulations were used.